Trial Design Webinars

  1. Mastering Scope 3 Emissions In Clinical Trials 10/23/2024

    Explore innovative strategies for reducing Scope 3 emissions in clinical trials. Discover sustainable solutions that uphold quality and outcomes, crucial for achieving net-zero goals in healthcare research.

  2. Investigator SmartSelect 10/23/2024

    This advanced recommendation engine identifies protocol-specific investigators in just minutes, dramatically shortening a process that typically takes four to six weeks.

  3. The Next Frontier In Early Phase Oncology Trials 10/18/2024

    This session explores the pivotal role of First-in-Human and early phase oncology trials in drug development, emphasizing the importance of comprehensive planning for successful execution.

  4. Anticipating And Adapting At Every Step Of Development 10/18/2024

    Review how Parexel's Oncology Site Alliance Network can support the accelerated timelines and flexibility required in early phase oncology studies.

  5. Oncology Clinical Trials Key Considerations: Planning For Success 10/18/2024

    Chief Scientific Officer Gabriel Kremmidiotis and CEO Yvonne Lungershausen from Avance Clinical delve into key strategies for conducting successful early-phase oncology trials for biotechs.

  6. Accelerate Your Trial With Data-Driven Site And Patient Identification 10/16/2024

    Acquire expert recommendations for the optimal sites to open your trials and find eligible patients directly at the point-of-care.

  7. From Crisis To Confidence: Ensuring Smooth Regulatory Submissions 10/8/2024

    Explore some of the major challenges that medical writing submission specialists face today and strategies that can consistently set the stage for success.

  8. The Golden Era Of GLP-1 Drugs 10/8/2024

    As GLP-1 drugs reshape the market, understanding their potential risks, applications, and economic effects is crucial for professionals in the pharmaceutical and healthcare industries.

  9. What Is Citeline Connect? 9/24/2024

    Explore a centralized patient recruitment platform that enables sponsors to meet their enrollment goals using a diverse selection of channels and recruitment partners.

  10. Race is a U.S. construct. 9/19/2024

    Stacey Bledsoe of Gilead Sciences stresses that when we look for “diverse” trial participants outside of the U.S., it may be difficult to find participants who identify the way we in the U.S. do.